HER2 status is assessed on a tumor biopsy by immunohistochemical (IHC) staining for HER2 protein on the cell membrane or by in situ hybridization (ISH) to identify HER2 gene amplification.3 This evidence concerns the gene ERBB2 and neoplasm.